Stock & Company Details
Gain Therapeutics Inc $GANX
Price:
N/A
N/A
44M
$70M
52 Week High:
N/A
10 Day Average Volume:
N/A
-2.71
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
GANX technical indicators
Latest Gain Therapeutics Inc (GANX) indicator readings as of 2026-10-09.
GANX's 14-day RSI is 39.2, in neutral territory. At $1.64 it is trading 16.8% below its 200-day moving average of $1.97, and below its 50-day average of $1.82. Price sits near the lower Bollinger Band ($1.59 to $1.90). ADX reads 12.1, indicating a range-bound market rather than a trend.
Overview
Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across, several therapeutics areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders and oncology. The company has filed four patent applications for novel small molecule drug candidates that are Structurally Targeted Allosteric Regulators (STARs). The company derives revenues from collaboration and licensing agreements.
Finance Bot
Ask your questions
Start by typing a question below.
